New Research Poster Presentation 2.50
The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Can Predict Both Better Treatment Response to Methylphenidate and Greater Neuropsychological Improvement in Children With ADHD
The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Can Predict Both Better Treatment Response to Methylphenidate and Greater Neuropsychological Improvement in Children With ADHD
Thursday, October 23, 2014 10:00 AM